Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Advances on the Role of Ferroptosis in Ionizing Radiation Response

Author(s): Fang Wang, QingHui Dai, Luhan Xu, Lu Gan, Yidi Shi, Mingjun Yang* and Shuhong Yang

Volume 25, Issue 4, 2024

Published on: 04 September, 2023

Page: [396 - 410] Pages: 15

DOI: 10.2174/1389201024666230823091144

Price: $65

Open Access Journals Promotions 2
Abstract

Ferroptosis is an iron-dependent programmed cell death mode that is distinct from other cell death modes, and radiation is able to stimulate cellular oxidative stress and induce the production of large amounts of reactive oxygen radicals, which in turn leads to the accumulation of lipid peroxide and the onset of ferroptosis. In this review, from the perspective of the role of ferroptosis in generating a radiation response following cellular irradiation, the relationship between ferroptosis induced by ionizing radiation stress and the response to ionizing radiation is reviewed, including the roles of MAPK and Nrf2 signaling pathways in ferroptosis, resulting from the oxidative stress response to ionizing radiation, the metabolic regulatory role of the p53 gene in ferroptosis, and regulatory modes of action of iron metabolism and iron metabolism-related regulatory proteins in promoting and inhibiting ferroptosis. It provides some ideas for the follow-up research to explore the specific mechanism and regulatory network of ferroptosis in response to ionizing radiation.

Keywords: Ionizing radiation response, ferroptosis, lipid peroxides, regulation of iron metabolism, reactive oxygen radicals, radiotherapy.

« Previous Next »
Graphical Abstract

[1]
Wang, K.; Tepper, J.E. Radiation therapy-associated toxicity: Etiology, management, and prevention. CA Cancer J. Clin., 2021, 71(5), 437-454.
[http://dx.doi.org/10.3322/caac.21689] [PMID: 34255347]
[2]
Zeng, J.; Harris, T.J.; Lim, M.; Drake, C.G.; Tran, P.T. (2013) Immune modulation and stereotactic radiation: improving local and abscopal responses. BioMed Res. Int., 2013, 658126.
[http://dx.doi.org/10.1155/2013/658126] [PMID: 24324970]
[3]
Tang, D.; Chen, X.; Kang, R.; Kroemer, G. Ferroptosis: Molecular mechanisms and health implications. Cell Res., 2021, 31(2), 107-125.
[http://dx.doi.org/10.1038/s41422-020-00441-1] [PMID: 33268902]
[4]
Helm, J.S.; Rudel, R.A. Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast. Arch. Toxicol., 2020, 94(5), 1511-1549.
[http://dx.doi.org/10.1007/s00204-020-02752-z] [PMID: 32399610]
[5]
Noda, A. Radiation-induced unrepairable DSBs: Their role in the late effects of radiation and possible applications to biodosimetry. J. Radiat. Res., 2018, 59(2), ii114-ii120.
[http://dx.doi.org/10.1093/jrr/rrx074] [PMID: 29281054]
[6]
Yu, C.; Peng, R.Y. Biological effects and mechanisms of shortwave radiation: A review. Mil. Med. Res., 2017, 4(1), 24.
[http://dx.doi.org/10.1186/s40779-017-0133-6] [PMID: 28729909]
[7]
Chen, X.; Kang, R.; Kroemer, G.; Tang, D. Broadening horizons: The role of ferroptosis in cancer. Nat. Rev. Clin. Oncol., 2021, 18(5), 280-296.
[http://dx.doi.org/10.1038/s41571-020-00462-0] [PMID: 33514910]
[8]
Gan, B. DUBbing ferroptosis in cancer cells. Cancer Res., 2019, 79(8), 1749-1750.
[http://dx.doi.org/10.1158/0008-5472.CAN-19-0487] [PMID: 30987975]
[9]
Dixon, S.J.; Lemberg, K.M.; Lamprecht, M.R.; Skouta, R.; Zaitsev, E.M.; Gleason, C.E.; Patel, D.N.; Bauer, A.J.; Cantley, A.M.; Yang, W.S.; Morrison, B., III; Stockwell, B.R. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 2012, 149(5), 1060-1072.
[http://dx.doi.org/10.1016/j.cell.2012.03.042] [PMID: 22632970]
[10]
Tang, D.; Kroemer, G. Ferroptosis. Curr. Biol., 2020, 30(21), R1292-R1297.
[http://dx.doi.org/10.1016/j.cub.2020.09.068] [PMID: 33142092]
[11]
Stockwell, B.R. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell, 2022, 185(14), 2401-2421.
[http://dx.doi.org/10.1016/j.cell.2022.06.003] [PMID: 35803244]
[12]
Yuan, H.; Pratte, J.; Giardina, C. Ferroptosis and its potential as a therapeutic target. Biochem. Pharmacol., 2021, 186, 114486.
[http://dx.doi.org/10.1016/j.bcp.2021.114486] [PMID: 33631189]
[13]
Jiang, X.; Stockwell, B.R.; Conrad, M. Ferroptosis: Mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol., 2021, 22(4), 266-282.
[http://dx.doi.org/10.1038/s41580-020-00324-8] [PMID: 33495651]
[14]
Feng, H.; Schorpp, K.; Jin, J.; Yozwiak, C.E.; Hoffstrom, B.G.; Decker, A.M.; Rajbhandari, P.; Stokes, M.E.; Bender, H.G.; Csuka, J.M.; Upadhyayula, P.S.; Canoll, P.; Uchida, K.; Soni, R.K.; Hadian, K.; Stockwell, B.R. Transferrin receptor is a specific ferroptosis marker. Cell Rep., 2020, 30(10), 3411-3423.e7.
[http://dx.doi.org/10.1016/j.celrep.2020.02.049] [PMID: 32160546]
[15]
Luo, M.; Yan, J.; Hu, X.; Li, H.; Li, H.; Liu, Q.; Chen, Y.; Zou, Z. Targeting lipid metabolism for ferroptotic cancer therapy. Apoptosis, 2022, •••, 18.
[http://dx.doi.org/10.1007/s10495-022-01795-0] [PMID: 36399287]
[16]
Zheng, J.; Conrad, M. The metabolic underpinnings of ferroptosis. Cell Metab., 2020, 32(6), 920-937.
[http://dx.doi.org/10.1016/j.cmet.2020.10.011] [PMID: 33217331]
[17]
Dahlmanns, M.; Yakubov, E.; Chen, D.; Sehm, T.; Rauh, M.; Savaskan, N.; Wrosch, J.K. Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Discov., 2017, 3(1), 17030.
[http://dx.doi.org/10.1038/cddiscovery.2017.30] [PMID: 28835855]
[18]
Zhang, Y.; Shi, J.; Liu, X.; Feng, L.; Gong, Z.; Koppula, P.; Sirohi, K.; Li, X.; Wei, Y.; Lee, H.; Zhuang, L.; Chen, G.; Xiao, Z.D.; Hung, M.C.; Chen, J.; Huang, P.; Li, W.; Gan, B. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat. Cell Biol., 2018, 20(10), 1181-1192.
[http://dx.doi.org/10.1038/s41556-018-0178-0] [PMID: 30202049]
[19]
Li, J.; Cao, F.; Yin, H.; Huang, Z.; Lin, Z.; Mao, N.; Sun, B.; Wang, G. Ferroptosis: Past, present and future. Cell Death Dis., 2020, 11(2), 88.
[http://dx.doi.org/10.1038/s41419-020-2298-2] [PMID: 32015325]
[20]
Bogdan, A.R.; Miyazawa, M.; Hashimoto, K.; Tsuji, Y. Regulators of Iron homeostasis: New players in metabolism, cell death, and disease. Trends Biochem. Sci., 2016, 41(3), 274-286.
[http://dx.doi.org/10.1016/j.tibs.2015.11.012] [PMID: 26725301]
[21]
Lei, G.; Mao, C.; Yan, Y.; Zhuang, L.; Gan, B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell, 2021, 12(11), 836-857.
[http://dx.doi.org/10.1007/s13238-021-00841-y] [PMID: 33891303]
[22]
Valashedi, M.R.; Bamshad, C.; Najafi-Ghalehlou, N.; Nikoo, A.; Tomita, K.; Kuwahara, Y.; Sato, T.; Roushandeh, A.M.; Roudkenar, M.H. Non-coding RNAs in ferroptotic cancer cell death pathway: Meet the new masters. Hum. Cell, 2022, 35(4), 972-994.
[http://dx.doi.org/10.1007/s13577-022-00699-0] [PMID: 35415781]
[23]
Liu, P.; Feng, Y.; Li, H.; Chen, X.; Wang, G.; Xu, S.; Li, Y.; Zhao, L. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis. Cell. Mol. Biol. Lett., 2020, 25(1), 10.
[http://dx.doi.org/10.1186/s11658-020-00205-0] [PMID: 32161620]
[24]
Dächert, J.; Ehrenfeld, V.; Habermann, K.; Dolgikh, N.; Fulda, S. Targeting ferroptosis in rhabdomyosarcoma cells. Int. J. Cancer, 2020, 146(2), 510-520.
[http://dx.doi.org/10.1002/ijc.32496] [PMID: 31173656]
[25]
Feng, S-Q.; Yao, X.; Zhang, Y.; Hao, J.; Duan, H-Q.; Zhao, C-X.; Sun, C.; Li, B.; Fan, B-Y.; Wang, X.; Li, W-X.; Fu, X-H.; Hu, Y.; Liu, C.; Kong, X-H. Deferoxamine promotes recovery of traumatic spinal cord injury by inhibiting ferroptosis. Neural Regen. Res., 2019, 14(3), 532-541.
[http://dx.doi.org/10.4103/1673-5374.245480] [PMID: 30539824]
[26]
Cao, Y.; Li, Y.; He, C.; Yan, F.; Li, J.R.; Xu, H.Z.; Zhuang, J.F.; Zhou, H.; Peng, Y.C.; Fu, X.J.; Lu, X.Y.; Yao, Y.; Wei, Y.Y.; Tong, Y.; Zhou, Y.F.; Wang, L. Selective ferroptosis inhibitor liproxstatin-1 attenuates neurological deficits and neuroinflammation after subarachnoid hemorrhage. Neurosci. Bull., 2021, 37(4), 535-549.
[http://dx.doi.org/10.1007/s12264-020-00620-5] [PMID: 33421025]
[27]
Jiang, T.; Chu, J.; Chen, H.; Cheng, H.; Su, J.; Wang, X.; Cao, Y.; Tian, S.; Li, Q. Gastrodin inhibits H2O2-induced ferroptosis through its antioxidative effect in rat glioma cell line C6. Biol. Pharm. Bull., 2020, 43(3), 480-487.
[http://dx.doi.org/10.1248/bpb.b19-00824] [PMID: 32115506]
[28]
Xiao, F.J.; Zhang, D.; Wu, Y.; Jia, Q.H.; Zhang, L.; Li, Y.X.; Yang, Y.F.; Wang, H.; Wu, C.T.; Wang, L.S. miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis. Biochem. Biophys. Res. Commun., 2019, 515(3), 448-454.
[http://dx.doi.org/10.1016/j.bbrc.2019.05.147] [PMID: 31160087]
[29]
Sun, X.; Ou, Z.; Chen, R.; Niu, X.; Chen, D.; Kang, R.; Tang, D. Activation of the p62Keap1NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology, 2016, 63(1), 173-184.
[http://dx.doi.org/10.1002/hep.28251] [PMID: 26403645]
[30]
Wang, B.; Hou, D.; Liu, Q.; Wu, T.; Guo, H.; Zhang, X.; Zou, Y.; Liu, Z.; Liu, J.; Wei, J.; Gong, Y.; Shao, C. Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51. Cancer Biol. Ther., 2015, 16(10), 1548-1556.
[http://dx.doi.org/10.1080/15384047.2015.1071738] [PMID: 26176175]
[31]
Gaschler, M.M.; Andia, A.A.; Liu, H.; Csuka, J.M.; Hurlocker, B.; Vaiana, C.A.; Heindel, D.W.; Zuckerman, D.S.; Bos, P.A.O.; Reznik, E.; Ye, L.F.; Tyurina, Y.Y.; Lin, A.J.; Shchepinov, M.S.; Chan, A.Y.; Peguero-Pereira, E.; Fomich, M.A.; Daniels, J.D.; Bekish, A.V.; Shmanai, V.A.O.; Kagan, V.E.; Mahal, L.K.; Woerpel, K.A.; Stockwell, B.R. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat. Chem. Biol., 2018, 14(5), 507-515.
[http://dx.doi.org/10.1038/s41589-018-0031-6] [PMID: 29610484]
[32]
Ma, S.; Henson, E.S.; Chen, Y.; Gibson, S.B. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis., 2016, 7(7), e2307.
[http://dx.doi.org/10.1038/cddis.2016.208] [PMID: 27441659]
[33]
Du, Y.; Bao, J.; Zhang, M.; Li, L.; Xu, X.L.; Chen, H.; Feng, Y.; Peng, X.; Chen, F. Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway. Gene, 2020, 755, 144889.
[http://dx.doi.org/10.1016/j.gene.2020.144889] [PMID: 32534056]
[34]
Chen, X.; Xu, S.; Zhao, C.; Liu, B. Role of TLR4/NADPH oxidase 4 pathway in promoting cell death through autophagy and ferroptosis during heart failure. Biochem. Biophys. Res. Commun., 2019, 516(1), 37-43.
[http://dx.doi.org/10.1016/j.bbrc.2019.06.015] [PMID: 31196626]
[35]
Mikulska-Ruminska, K.; Anthonymuthu, T.; Levkina, A.; Shrivastava, I.; Kapralov, A. Bayır, H.; Kagan, V.; Bahar, I. NO● represses the oxygenation of arachidonoyl PE by 15LOX/PEBP1: Mechanism and role in ferroptosis. Int. J. Mol. Sci., 2021, 22(10), 5253.
[http://dx.doi.org/10.3390/ijms22105253] [PMID: 34067535]
[36]
Badgley, M.A.; Kremer, D.M.; Maurer, H.C.; DelGiorno, K.E.; Lee, H.J.; Purohit, V.; Sagalovskiy, I.R.; Ma, A.; Kapilian, J.; Firl, C.E.M.; Decker, A.R.; Sastra, S.A.; Palermo, C.F.; Andrade, L.R.; Sajjakulnukit, P.; Zhang, L.; Tolstyka, Z.P.; Hirschhorn, T.; Lamb, C.; Liu, T.; Gu, W.; Seeley, E.S.; Stone, E.; Georgiou, G.; Manor, U.; Iuga, A.; Wahl, G.M.; Stockwell, B.R.; Lyssiotis, C.A.; Olive, K.P. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Sci., 2020, 368(6486), 85-89.
[http://dx.doi.org/10.1126/science.aaw9872] [PMID: 32241947]
[37]
Eaton, J.K.; Furst, L.; Ruberto, R.A.; Moosmayer, D.; Hilpmann, A.; Ryan, M.J.; Zimmermann, K.; Cai, L.L.; Niehues, M.; Badock, V.; Kramm, A.; Chen, S.; Hillig, R.C.; Clemons, P.A.; Gradl, S.; Montagnon, C.; Lazarski, K.E.; Christian, S.; Bajrami, B.; Neuhaus, R.; Eheim, A.L.; Viswanathan, V.S.; Schreiber, S.L. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat. Chem. Biol., 2020, 16(5), 497-506.
[http://dx.doi.org/10.1038/s41589-020-0501-5] [PMID: 32231343]
[38]
NaveenKumar, S.K.; Hemshekhar, M.; Kemparaju, K.; Girish, K.S. Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by Melatonin. Biochim. Biophys. Acta Mol. Basis Dis., 2019, 1865(9), 2303-2316.
[http://dx.doi.org/10.1016/j.bbadis.2019.05.009] [PMID: 31102787]
[39]
Doll, S.; Freitas, F.P.; Shah, R.; Aldrovandi, M.; da Silva, M.C.; Ingold, I.; Goya Grocin, A.; Xavier da Silva, T.N.; Panzilius, E.; Scheel, C.H.; Mourão, A.; Buday, K.; Sato, M.; Wanninger, J.; Vignane, T.; Mohana, V.; Rehberg, M.; Flatley, A.; Schepers, A.; Kurz, A.; White, D.; Sauer, M.; Sattler, M.; Tate, E.W.; Schmitz, W.; Schulze, A.; O’Donnell, V.; Proneth, B.; Popowicz, G.M.; Pratt, D.A.; Angeli, J.P.F.; Conrad, M. FSP1 is a glutathione-independent ferroptosis suppressor. Nature, 2019, 575(7784), 693-698.
[http://dx.doi.org/10.1038/s41586-019-1707-0] [PMID: 31634899]
[40]
Yu, Y.; Huang, Z.; Chen, Q.; Zhang, Z.; Jiang, H.; Gu, R.; Ding, Y.; Hu, Y. Iron-based nanoscale coordination polymers synergistically induce immunogenic ferroptosis by blocking dihydrofolate reductase for cancer immunotherapy. Biomaterials, 2022, 288, 121724.
[http://dx.doi.org/10.1016/j.biomaterials.2022.121724] [PMID: 36038420]
[41]
Wang, S.; Li, F.; Qiao, R.; Hu, X.; Liao, H.; Chen, L.; Wu, J.; Wu, H.; Zhao, M.; Liu, J.; Chen, R.; Ma, X.; Kim, D.; Sun, J.; Davis, T.P.; Chen, C.; Tian, J.; Hyeon, T.; Ling, D. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics. ACS Nano, 2018, 12(12), 12380-12392.
[http://dx.doi.org/10.1021/acsnano.8b06399] [PMID: 30495919]
[42]
Hsieh, C.H.; Hsieh, H.C.; Shih, F.H.; Wang, P.W.; Yang, L.X.; Shieh, D.B.; Wang, Y.C. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Theranostics, 2021, 11(14), 7072-7091.
[http://dx.doi.org/10.7150/thno.57803] [PMID: 34093872]
[43]
Huo, M.; Wang, L.; Wang, Y.; Chen, Y.; Shi, J. Nanocatalytic tumor therapy by single-atom catalysts. ACS Nano., 2019, 13(2), acsnano.9b00457..
[http://dx.doi.org/10.1021/acsnano.9b00457] [PMID: 30753056]
[44]
Miao, M.Z.; Xiao, P.G.; Yue, G.; Wen, J.; Dong, L. A review of the effects of ionizing radiation on cell membrane. J. Radiat. Res. Radiat. Technol., 2017, 35(4), 040103-040107.
[http://dx.doi.org/10.11889/j.1000-3436.2017.rrj.35.040103]
[45]
Hassannia, B.; Van Coillie, S.; Vanden Berghe, T. Ferroptosis: Biological rust of lipid membranes. Antioxid. Redox Signal., 2021, 35(6), 487-509.
[http://dx.doi.org/10.1089/ars.2020.8175] [PMID: 32808533]
[46]
Stockwell, B.R.; Friedmann Angeli, J.P.; Bayir, H.; Bush, A.I.; Conrad, M.; Dixon, S.J.; Fulda, S.; Gascón, S.; Hatzios, S.K.; Kagan, V.E.; Noel, K.; Jiang, X.; Linkermann, A.; Murphy, M.E.; Overholtzer, M.; Oyagi, A.; Pagnussat, G.C.; Park, J.; Ran, Q.; Rosenfeld, C.S.; Salnikow, K.; Tang, D.; Torti, F.M.; Torti, S.V.; Toyokuni, S.; Woerpel, K.A.; Zhang, D.D. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 2017, 171(2), 273-285.
[http://dx.doi.org/10.1016/j.cell.2017.09.021] [PMID: 28985560]
[47]
Wang, Y.; Liu, Z.G.; Yuan, H.; Deng, W.; Li, J.; Huang, Y.; Kim, B.Y.S.; Story, M.D.; Jiang, W. The reciprocity between radiotherapy and cancer immunotherapy. Clin. Cancer Res., 2019, 25(6), 1709-1717.
[http://dx.doi.org/10.1158/1078-0432.CCR-18-2581] [PMID: 30413527]
[48]
Lang, X.; Green, M.D.; Wang, W.; Yu, J.; Choi, J.E.; Jiang, L.; Liao, P.; Zhou, J.; Zhang, Q.; Dow, A.; Saripalli, A.L.; Kryczek, I.; Wei, S.; Szeliga, W.; Vatan, L.; Stone, E.M.; Georgiou, G.; Cieslik, M.; Wahl, D.R.; Morgan, M.A.; Chinnaiyan, A.M.; Lawrence, T.S.; Zou, W. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov., 2019, 9(12), 1673-1685.
[http://dx.doi.org/10.1158/2159-8290.CD-19-0338] [PMID: 31554642]
[49]
Wang, W.; Green, M.; Choi, J.E.; Gijón, M.; Kennedy, P.D.; Johnson, J.K.; Liao, P.; Lang, X.; Kryczek, I.; Sell, A.; Xia, H.; Zhou, J.; Li, G.; Li, J.; Li, W.; Wei, S.; Vatan, L.; Zhang, H.; Szeliga, W.; Gu, W.; Liu, R.; Lawrence, T.S.; Lamb, C.; Tanno, Y.; Cieslik, M.; Stone, E.; Georgiou, G.; Chan, T.A.; Chinnaiyan, A.; Zou, W. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature, 2019, 569(7755), 270-274.
[http://dx.doi.org/10.1038/s41586-019-1170-y] [PMID: 31043744]
[50]
Wang, H.; Mu, X.; He, H.; Zhang, X.D. Cancer radiosensitizers. Trends Pharmacol. Sci., 2018, 39(1), 24-48.
[http://dx.doi.org/10.1016/j.tips.2017.11.003] [PMID: 29224916]
[51]
Cadenas, S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic. Biol. Med., 2018, 117, 76-89.
[http://dx.doi.org/10.1016/j.freeradbiomed.2018.01.024] [PMID: 29373843]
[52]
Santivasi, W.L.; Xia, F. Ionizing radiation-induced DNA damage, response, and repair. Antioxid. Redox Signal., 2014, 21(2), 251-259.
[http://dx.doi.org/10.1089/ars.2013.5668] [PMID: 24180216]
[53]
Yan, B.; Ai, Y.; Sun, Q.; Ma, Y.; Cao, Y.; Wang, J.; Zhang, Z.; Wang, X. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol. Cell, 2021, 81(2), 355-369.e10.
[http://dx.doi.org/10.1016/j.molcel.2020.11.024] [PMID: 33321093]
[54]
Panzetta, V.; La Verde, G.; Pugliese, M.; Artiola, V.; Arrichiello, C.; Muto, P.; La Commara, M.; Netti, P.A.; Fusco, S. Adhesion and migration response to radiation therapy of mammary epithelial and adenocarcinoma cells interacting with different stiffness substrates. Cancers, 2020, 12(5), 1170.
[http://dx.doi.org/10.3390/cancers12051170] [PMID: 32384675]
[55]
Imai, H.; Matsuoka, M.; Kumagai, T.; Sakamoto, T.; Koumura, T. Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Curr. Top. Microbiol. Immunol., 2016, 403, 143-170.
[http://dx.doi.org/10.1007/82_2016_508] [PMID: 28204974]
[56]
Ye, L.F.; Chaudhary, K.R.; Zandkarimi, F.; Harken, A.D.; Kinslow, C.J.; Upadhyayula, P.S.; Dovas, A.; Higgins, D.M.; Tan, H.; Zhang, Y.; Buonanno, M.; Wang, T.J.C.; Hei, T.K.; Bruce, J.N.; Canoll, P.D.; Cheng, S.K.; Stockwell, B.R. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem. Biol., 2020, 15(2), 469-484.
[http://dx.doi.org/10.1021/acschembio.9b00939] [PMID: 31899616]
[57]
Dixon, S.J.; Winter, G.E.; Musavi, L.S.; Lee, E.D.; Snijder, B.; Rebsamen, M.; Superti-Furga, G.; Stockwell, B.R. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem. Biol., 2015, 10(7), 1604-1609.
[http://dx.doi.org/10.1021/acschembio.5b00245] [PMID: 25965523]
[58]
Nakamura, T.; Naguro, I.; Ichijo, H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim. Biophys. Acta, Gen. Subj., 2019, 1863(9), 1398-1409.
[http://dx.doi.org/10.1016/j.bbagen.2019.06.010] [PMID: 31229492]
[59]
Lin, Z.; Liu, J.; Kang, R.; Yang, M.; Tang, D. Lipid metabolism in ferroptosis. Adv. Biol., 2021, 5(8), 2100396.
[http://dx.doi.org/10.1002/adbi.202100396] [PMID: 34015188]
[60]
Chen, X.; Yu, C.; Kang, R.; Tang, D. Iron metabolism in ferroptosis. Front. Cell Dev. Biol., 2020, 8, 590226.
[http://dx.doi.org/10.3389/fcell.2020.590226] [PMID: 33117818]
[61]
Zou, Y.; Henry, W.S.; Ricq, E.L.; Graham, E.T.; Phadnis, V.V.; Maretich, P.; Paradkar, S.; Boehnke, N.; Deik, A.A.; Reinhardt, F.; Eaton, J.K.; Ferguson, B.; Wang, W.; Fairman, J.; Keys, H.R. Dančík, V.; Clish, C.B.; Clemons, P.A.; Hammond, P.T.; Boyer, L.A.; Weinberg, R.A.; Schreiber, S.L. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature, 2020, 585(7826), 603-608.
[http://dx.doi.org/10.1038/s41586-020-2732-8] [PMID: 32939090]
[62]
Chang, L.C.; Chiang, S.K.; Chen, S.E.; Yu, Y.L.; Chou, R.H.; Chang, W.C. Heme oxygenase-1 mediates BAY 11–7085 induced ferroptosis. Cancer Lett., 2018, 416, 124-137.
[http://dx.doi.org/10.1016/j.canlet.2017.12.025] [PMID: 29274359]
[63]
Ursini, F.; Maiorino, M. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic. Biol. Med., 2020, 152, 175-185.
[http://dx.doi.org/10.1016/j.freeradbiomed.2020.02.027] [PMID: 32165281]
[64]
Sun, Y.; Berleth, N.; Wu, W.; Schlütermann, D.; Deitersen, J.; Stuhldreier, F.; Berning, L.; Friedrich, A.; Akgün, S.; Mendiburo, M.J.; Wesselborg, S.; Conrad, M.; Berndt, C.; Stork, B. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death Dis., 2021, 12(11), 1028.
[http://dx.doi.org/10.1038/s41419-021-04306-2] [PMID: 34716292]
[65]
Kabilan, U.; Graber, T.E.; Alain, T.; Klokov, D. Ionizing radiation and translation control: A link to radiation hormesis? Int. J. Mol. Sci., 2020, 21(18), 6650.
[http://dx.doi.org/10.3390/ijms21186650] [PMID: 32932812]
[66]
Zhang, X.; Xing, X.; Liu, H.; Feng, J.; Tian, M.; Chang, S.; Liu, P.; Zhang, H. Ionizing radiation induces ferroptosis in granulocyte-macrophage hematopoietic progenitor cells of murine bone marrow. Int. J. Radiat. Biol., 2020, 96(5), 584-595.
[http://dx.doi.org/10.1080/09553002.2020.1708993] [PMID: 31906761]
[67]
Li, X.Y.; Leung, P.S. Erastin-induced ferroptosis is a regulator for the growth and function of human pancreatic islet-like cell clusters. Cell Regen., 2020, 9(1), 16.
[http://dx.doi.org/10.1186/s13619-020-00055-3] [PMID: 32893325]
[68]
Regon, P.; Dey, S.; Chowardhara, B.; Saha, B.; Kar, S.; Tanti, B.; Panda, S.K. Physio-biochemical and molecular assessment of Iron (Fe2+) toxicity responses in contrasting indigenous aromatic joha rice cultivars of Assam, India. Protoplasma, 2021, 258(2), 289-299.
[http://dx.doi.org/10.1007/s00709-020-01574-1] [PMID: 33070240]
[69]
Bersuker, K.; Hendricks, J.M.; Li, Z.; Magtanong, L.; Ford, B.; Tang, P.H.; Roberts, M.A.; Tong, B.; Maimone, T.J.; Zoncu, R.; Bassik, M.C.; Nomura, D.K.; Dixon, S.J.; Olzmann, J.A. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature, 2019, 575(7784), 688-692.
[http://dx.doi.org/10.1038/s41586-019-1705-2] [PMID: 31634900]
[70]
Chen, L.; Xie, J. Ferroptosis suppressor protein 1: A potential neuroprotective target for combating ferroptosis. Mov. Disord., 2020, 35(3), 400.
[http://dx.doi.org/10.1002/mds.27990] [PMID: 32027037]
[71]
Vogt, A.C.S.; Arsiwala, T.; Mohsen, M.; Vogel, M.; Manolova, V.; Bachmann, M.F. On iron metabolism and its regulation. Int. J. Mol. Sci., 2021, 22(9), 4591.
[http://dx.doi.org/10.3390/ijms22094591] [PMID: 33925597]
[72]
Gao, J.; Luo, T.; Wang, J. Gene interfered-ferroptosis therapy for cancers. Nat. Commun., 2021, 12(1), 5311.
[http://dx.doi.org/10.1038/s41467-021-25632-1] [PMID: 34493724]
[73]
Bao, W.D.; Pang, P.; Zhou, X.T.; Hu, F.; Xiong, W.; Chen, K.; Wang, J.; Wang, F.; Xie, D.; Hu, Y.Z.; Han, Z.T.; Zhang, H.H.; Wang, W.X.; Nelson, P.T.; Chen, J.G.; Lu, Y.; Man, H.Y.; Liu, D.; Zhu, L.Q. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease. Cell Death Differ., 2021, 28(5), 1548-1562.
[http://dx.doi.org/10.1038/s41418-020-00685-9] [PMID: 33398092]
[74]
Sporn, M.B.; Liby, K.T. NRF2 and cancer: The good, the bad and the importance of context. Nat. Rev. Cancer, 2012, 12(8), 564-571.
[http://dx.doi.org/10.1038/nrc3278] [PMID: 22810811]
[75]
Ke, K.; Li, L.; Lu, C.; Zhu, Q.; Wang, Y.; Mou, Y.; Wang, H.; Jin, W. The crosstalk effect between ferrous and other ions metabolism in ferroptosis for therapy of cancer. Front. Oncol., 2022, 12, 916082.
[http://dx.doi.org/10.3389/fonc.2022.916082] [PMID: 36033459]
[76]
Gan, B. Mitochondrial regulation of ferroptosis. J. Cell Biol., 2021, 220(9), e202105043.
[http://dx.doi.org/10.1083/jcb.202105043] [PMID: 34328510]
[77]
Shui, S.; Zhao, Z.; Wang, H.; Conrad, M.; Liu, G. Non-enzymatic lipid peroxidation initiated by photodynamic therapy drives a distinct ferroptosis-like cell death pathway. Redox Biol., 2021, 45, 102056.
[http://dx.doi.org/10.1016/j.redox.2021.102056] [PMID: 34229160]
[78]
Lu, J.; Holmgren, A. Selenoproteins. J. Biol. Chem., 2009, 284(2), 723-727.
[http://dx.doi.org/10.1074/jbc.R800045200] [PMID: 18757362]
[79]
Short, S.P.; Williams, C.S. Selenoproteins in tumorigenesis and cancer progression. Adv. Cancer Res., 2017, 136, 49-83.
[http://dx.doi.org/10.1016/bs.acr.2017.08.002] [PMID: 29054422]
[80]
Wu, H.; Luan, Y.; Wang, H.; Zhang, P.; Liu, S.; Wang, P.; Cao, Y.; Sun, H.; Wu, L. Selenium inhibits ferroptosis and ameliorates autistic-like behaviors of BTBR mice by regulating the Nrf2/GPx4 pathway. Brain Res. Bull., 2022, 183, 38-48.
[http://dx.doi.org/10.1016/j.brainresbull.2022.02.018] [PMID: 35227767]
[81]
Angeli, F.J.P.; Conrad, M. Selenium and GPX4, a vital symbiosis. Free Radic. Biol. Med., 2018, 127, 153-159.
[http://dx.doi.org/10.1016/j.freeradbiomed.2018.03.001] [PMID: 29522794]
[82]
Liu, L.; Wang, M.; Gong, N.; Tian, P.; Deng, H. Se improves GPX4 expression and SOD activity to alleviate heat-stress-induced ferroptosis-like death in goat mammary epithelial cells. Anim. Cells Syst., 2021, 25(5), 283-295.
[http://dx.doi.org/10.1080/19768354.2021.1988704] [PMID: 34745435]
[83]
Dineley, K.E.; Votyakova, T.V.; Reynolds, I.J. Zinc inhibition of cellular energy production: Implications for mitochondria and neurodegeneration. J. Neurochem., 2003, 85(3), 563-570.
[http://dx.doi.org/10.1046/j.1471-4159.2003.01678.x] [PMID: 12694382]
[84]
Lee, S.R. Critical role of zinc as either an antioxidant or a prooxidant in cellular systems. Oxid. Med. Cell. Longev., 2018, 2018, 1-11.
[http://dx.doi.org/10.1155/2018/9156285] [PMID: 29743987]
[85]
Wang, B.; Li, D.; Kovalchuk, O. p53 Ser15 phosphorylation and histone modifications contribute to IR-induced miR-34a transcription in mammary epithelial cells. Cell Cycle, 2013, 12(13), 2073-2083.
[http://dx.doi.org/10.4161/cc.25135] [PMID: 23759592]
[86]
Chen, J.; Zhang, D.; Qin, X.; Owzar, K.; McCann, J.J.; Kastan, M.B. DNA-damage-induced alternative splicing of p53. Cancers, 2021, 13(2), 251.
[http://dx.doi.org/10.3390/cancers13020251] [PMID: 33445417]
[87]
Hassin, O.; Oren, M. Drugging p53 in cancer: One protein, many targets. Nat. Rev. Drug Discov., 2022, •••, 1-18.
[http://dx.doi.org/10.1038/s41573-022-00571-8] [PMID: 36216888]
[88]
Chen, S.L.; Zhang, C.Z.; Liu, L.L.; Lu, S.X.; Pan, Y.H.; Wang, C.H.; He, Y.F.; Lin, C.S.; Yang, X.; Xie, D.; Yun, J.P.A. GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma. Cancer Res., 2019, 79(3), 534-545.
[http://dx.doi.org/10.1158/0008-5472.CAN-18-2357] [PMID: 30584071]
[89]
O’Connor, P.M.; Jackman, J.; Bae, I.; Myers, T.G.; Fan, S.; Mutoh, M.; Scudiero, D.A.; Monks, A.; Sausville, E.A.; Weinstein, J.N.; Friend, S.; Fornace, A.J., Jr; Kohn, K.W. Characterization of the p53 tumor suppressor pathway in cell lines of the national cancer institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 1997, 57(19), 4285-4300.
[PMID: 9331090]
[90]
Werbrouck, C.; Evangelista, C.C.S.; Lobón-Iglesias, M.J.; Barret, E.; Le Teuff, G.; Merlevede, J.; Brusini, R.; Kergrohen, T.; Mondini, M.; Bolle, S.; Varlet, P.; Beccaria, K.; Boddaert, N.; Puget, S.; Grill, J.; Debily, M.A.; Castel, D. TP53 pathway alterations drive radioresistance in diffuse intrinsic pontine gliomas (DIPG). Clin. Cancer Res., 2019, 25(22), 6788-6800.
[http://dx.doi.org/10.1158/1078-0432.CCR-19-0126] [PMID: 31481512]
[91]
Chen, X.; Zhang, T.; Su, W.; Dou, Z.; Zhao, D.; Jin, X.; Lei, H.; Wang, J.; Xie, X.; Cheng, B.; Li, Q.; Zhang, H.; Di, C. Mutant p53 in cancer: From molecular mechanism to therapeutic modulation. Cell Death Dis., 2022, 13(11), 974.
[http://dx.doi.org/10.1038/s41419-022-05408-1] [PMID: 36400749]
[92]
Ou, Y.; Wang, S.J.; Li, D.; Chu, B.; Gu, W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc. Natl. Acad. Sci., 2016, 113(44), E6806-E6812.
[http://dx.doi.org/10.1073/pnas.1607152113] [PMID: 27698118]
[93]
Wang, P.Y.; Ma, W.; Park, J.Y.; Celi, F.S.; Arena, R.; Choi, J.W.; Ali, Q.A.; Tripodi, D.J.; Zhuang, J.; Lago, C.U.; Strong, L.C.; Talagala, S.L.; Balaban, R.S.; Kang, J.G.; Hwang, P.M. Increased oxidative metabolism in the Li-Fraumeni syndrome. N. Engl. J. Med., 2013, 368(11), 1027-1032.
[http://dx.doi.org/10.1056/NEJMoa1214091] [PMID: 23484829]
[94]
Xie, Y.; Zhu, S.; Song, X.; Sun, X.; Fan, Y.; Liu, J.; Zhong, M.; Yuan, H.; Zhang, L.; Billiar, T.R.; Lotze, M.T.; Zeh, H.J., III; Kang, R.; Kroemer, G.; Tang, D. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep., 2017, 20(7), 1692-1704.
[http://dx.doi.org/10.1016/j.celrep.2017.07.055] [PMID: 28813679]
[95]
Simanshu, D.K.; Nissley, D.V.; McCormick, F. RAS proteins and their regulators in human disease. Cell, 2017, 170(1), 17-33.
[http://dx.doi.org/10.1016/j.cell.2017.06.009] [PMID: 28666118]
[96]
Shi, Z.; Liu, J.; Sun, D. Let-7a targets Rsf-1 to modulate radiotherapy response of non-small cell lung cancer cells through Ras-MAPK pathway. J. BUON, 2021, 26(4), 1422-1431.
[PMID: 34565000]
[97]
Levada, K.; Guldiken, N.; Zhang, X.; Vella, G.; Mo, F.R.; James, L.P.; Haybaeck, J.; Kessler, S.M.; Kiemer, A.K.; Ott, T.; Hartmann, D.; Hüser, N.; Ziol, M.; Trautwein, C.; Strnad, P. Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling. J. Hepatol., 2018, 68(5), 996-1005.
[http://dx.doi.org/10.1016/j.jhep.2018.01.003] [PMID: 29331340]
[98]
Wang, X.; Zhang, C.; Zou, N.; Chen, Q.; Wang, C.; Zhou, X.; Luo, L.; Qi, H.; Li, J.; Liu, Z.; Yi, J.; Li, J.; Liu, W. Lipocalin-2 silencing suppresses inflammation and oxidative stress of acute respiratory distress syndrome by ferroptosis via inhibition of MAPK/ERK pathway in neonatal mice. Bioengineered, 2022, 13(1), 508-520.
[http://dx.doi.org/10.1080/21655979.2021.2009970] [PMID: 34969358]
[99]
Krayem, M.; Sabbah, M.; Najem, A.; Wouters, A.; Lardon, F.; Simon, S.; Sales, F.; Journe, F.; Awada, A.; Ghanem, G.E.; Van Gestel, D. The benefit of reactivating p53 under mapk inhibition on the efficacy of radiotherapy in Melanoma. Cancers, 2019, 11(8), 1093.
[http://dx.doi.org/10.3390/cancers11081093] [PMID: 31374895]
[100]
Tonelli, C.; Chio, I.I.C.; Tuveson, D.A. Transcriptional regulation by Nrf2. Antioxid. Redox Signal., 2018, 29(17), 1727-1745.
[http://dx.doi.org/10.1089/ars.2017.7342] [PMID: 28899199]
[101]
Kobayashi, M.; Yamamoto, M. Nrf2–Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul., 2006, 46(1), 113-140.
[http://dx.doi.org/10.1016/j.advenzreg.2006.01.007] [PMID: 16887173]
[102]
Sato, Y.; Yoshizato, T.; Shiraishi, Y.; Maekawa, S.; Okuno, Y.; Kamura, T.; Shimamura, T.; Sato-Otsubo, A.; Nagae, G.; Suzuki, H.; Nagata, Y.; Yoshida, K.; Kon, A.; Suzuki, Y.; Chiba, K.; Tanaka, H.; Niida, A.; Fujimoto, A.; Tsunoda, T.; Morikawa, T.; Maeda, D.; Kume, H.; Sugano, S.; Fukayama, M.; Aburatani, H.; Sanada, M.; Miyano, S.; Homma, Y.; Ogawa, S. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet., 2013, 45(8), 860-867.
[http://dx.doi.org/10.1038/ng.2699] [PMID: 23797736]
[103]
Kim, B.; Nam, H.J.; Pyo, K.E.; Jang, M.J.; Kim, I.S.; Kim, D.; Boo, K.; Lee, S.H.; Yoon, J.B.; Baek, S.H.; Kim, J.H. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3–SPOP E3 ubiquitin ligase complex. Biochem. Biophys. Res. Commun., 2011, 415(4), 720-726.
[http://dx.doi.org/10.1016/j.bbrc.2011.10.154] [PMID: 22085717]
[104]
Liu, Q.; Wang, K. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. Cell Biol. Int., 2019, 43(11), 1245-1256.
[http://dx.doi.org/10.1002/cbin.11121] [PMID: 30811078]
[105]
Liu, N.; Lin, X.; Huang, C. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance. Br. J. Cancer, 2020, 122(2), 279-292.
[http://dx.doi.org/10.1038/s41416-019-0660-x] [PMID: 31819185]
[106]
Jiao, Y.; Cao, F.; Liu, H. Radiation-induced cell death and its mechanisms. Health Phys., 2022, 123(5), 376-386.
[http://dx.doi.org/10.1097/HP.0000000000001601] [PMID: 36069830]
[107]
Dodson, M.; Castro-Portuguez, R.; Zhang, D.D. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol., 2019, 23, 101107.
[http://dx.doi.org/10.1016/j.redox.2019.101107] [PMID: 30692038]
[108]
Huang, W.M.; Li, Z.X.; Wu, Y.H.; Shi, Z.L.; Mi, J.L.; Hu, K.; Wang, R.S. m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis. Transl. Oncol., 2023, 27, 101576.
[http://dx.doi.org/10.1016/j.tranon.2022.101576] [PMID: 36343416]
[109]
Lei, G.; Zhang, Y.; Koppula, P.; Liu, X.; Zhang, J.; Lin, S.H.; Ajani, J.A.; Xiao, Q.; Liao, Z.; Wang, H.; Gan, B. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res., 2020, 30(2), 146-162.
[http://dx.doi.org/10.1038/s41422-019-0263-3] [PMID: 31949285]
[110]
Beretta, G.L.; Zaffaroni, N. Radiotherapy-induced ferroptosis for cancer treatment. Front. Mol. Biosci., 2023, 10, 1216733.
[http://dx.doi.org/10.3389/fmolb.2023.1216733] [PMID: 37388241]
[111]
Zhang, Z.; Lu, M.; Chen, C.; Tong, X.; Li, Y.; Yang, K.; Lv, H.; Xu, J.; Qin, L. Holo-lactoferrin: The link between ferroptosis and radiotherapy in triple-negative breast cancer. Theranostics, 2021, 11(7), 3167-3182.
[http://dx.doi.org/10.7150/thno.52028] [PMID: 33537080]
[112]
Du, J.; Wang, T.; Li, Y.; Zhou, Y.; Wang, X.; Yu, X.; Ren, X.; An, Y.; Wu, Y.; Sun, W.; Fan, W.; Zhu, Q.; Wang, Y.; Tong, X. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radic. Biol. Med., 2019, 131, 356-369.
[http://dx.doi.org/10.1016/j.freeradbiomed.2018.12.011] [PMID: 30557609]
[113]
Yuan, S.; Wei, C.; Liu, G.; Zhang, L.; Li, J.; Li, L.; Cai, S.; Fang, L. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF1α/SLC7A11 pathway. Cell Prolif., 2022, 55(1), e13158.
[http://dx.doi.org/10.1111/cpr.13158] [PMID: 34811833]
[114]
Su, Y.; Zhao, B.; Zhou, L.; Zhang, Z.; Shen, Y.; Lv, H.; AlQudsy, L.H.H.; Shang, P. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett., 2020, 483, 127-136.
[http://dx.doi.org/10.1016/j.canlet.2020.02.015] [PMID: 32067993]
[115]
Sui, X.; Zhang, R.; Liu, S.; Duan, T.; Zhai, L.; Zhang, M.; Han, X.; Xiang, Y.; Huang, X.; Lin, H.; Xie, T. RSL3 drives ferroptosis through gpx4 inactivation and ros production in colorectal cancer. Front. Pharmacol., 2018, 9, 1371.
[http://dx.doi.org/10.3389/fphar.2018.01371] [PMID: 30524291]
[116]
Yao, X.; Xie, R.; Cao, Y.; Tang, J.; Men, Y.; Peng, H.; Yang, W. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J. Nanobiotechnology, 2021, 19(1), 311.
[http://dx.doi.org/10.1186/s12951-021-01058-1] [PMID: 34627266]
[117]
Li, Q.; Liu, C.; Deng, L.; Xie, E.; Yadav, N.; Tie, Y.; Cheng, Z.; Deng, J. Novel function of fluvastatin in attenuating oxidized low density lipoprotein induced endothelial cell ferroptosis in a glutathione peroxidase4 and cystine glutamate antiporter dependent manner. Exp. Ther. Med., 2021, 22(5), 1275.
[http://dx.doi.org/10.3892/etm.2021.10710] [PMID: 34594412]
[118]
Zhang, Y.; Tan, Y.; Liu, S.; Yin, H.; Duan, J.; Fan, L.; Zhao, X.; Jiang, B. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis. Toxicol. Mech. Methods, 2022, 33(1), 47-55.
[http://dx.doi.org/10.1080/15376516.2022.2075297] [PMID: 35592903]
[119]
Zhang, Y.; Tan, H.; Daniels, J.D.; Zandkarimi, F.; Liu, H.; Brown, L.M.; Uchida, K.; O’Connor, O.A.; Stockwell, B.R. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem. Biol., 2019, 26(5), 623-633.e9.
[http://dx.doi.org/10.1016/j.chembiol.2019.01.008] [PMID: 30799221]
[120]
Luo, Y.; Yan, P.; Li, X.; Hou, J.; Wang, Y.; Zhou, S. pH-Sensitive polymeric vesicles for GOx/BSO delivery and synergetic starvation-ferroptosis therapy of Tumor. Biomacromolecules, 2021, 22(10), 4383-4394.
[http://dx.doi.org/10.1021/acs.biomac.1c00960] [PMID: 34533297]
[121]
Shin, D.; Kim, E.H.; Lee, J.; Roh, J.L. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic. Biol. Med., 2018, 129, 454-462.
[http://dx.doi.org/10.1016/j.freeradbiomed.2018.10.426] [PMID: 30339884]
[122]
Motooka, Y.; Toyokuni, S. Ferroptosis as ultimate target of cancer therapy. Antioxid. Redox Signal., 2022.
[http://dx.doi.org/10.1089/ars.2022.0048] [PMID: 35943875]
[123]
Zhao, Y.; Zhao, W.; Lim, Y.C.; Liu, T. Salinomycin-loaded gold nanoparticles for treating cancer stem cells by ferroptosis-induced Cell Death. Mol. Pharm., 2019, 16(6), 2532-2539.
[http://dx.doi.org/10.1021/acs.molpharmaceut.9b00132] [PMID: 31009228]
[124]
Helbig, L.; Koi, L.; Brüchner, K.; Gurtner, K.; Hess-Stumpp, H.; Unterschemmann, K.; Baumann, M.; Zips, D.; Yaromina, A. BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. Radiat. Oncol., 2014, 9(1), 207.
[http://dx.doi.org/10.1186/1748-717X-9-207] [PMID: 25234922]
[125]
Llabani, E.; Hicklin, R.W.; Lee, H.Y.; Motika, S.E.; Crawford, L.A.; Weerapana, E.; Hergenrother, P.J. Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis. Nat. Chem., 2019, 11(6), 521-532.
[http://dx.doi.org/10.1038/s41557-019-0261-6] [PMID: 31086302]

Rights & Permissions Print Cite
Article Metrics
36
2
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy